Pfizer Geodon “not approvable”
Executive Summary
Pfizer is responding to FDA "not approvable" letter for Geodon liquid oral suspension, company says in Aug. 13 filing with Securities & Exchange Commission. Pfizer received the ziprasidone action letter in July after submitting the sNDA in October 2002...